LPAAW
FinancialsLaunch One Acquisition Corp - Warrants(13/06/2029)
Live · NASDAQ · May 9, Close
What's Moving LPAAW Today?
No stock-specific AI insight has been generated for LPAAW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.11
Fundamentals
Trading
LPAAW News
6 articles- Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic SyndromeYahoo Finance·Oct 15, 2025
- Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic SyndromeYahoo Finance·Sep 18, 2025
- Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based BiomarkersYahoo Finance·Aug 27, 2025
- Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by GrowthYahoo Finance·Jul 24, 2025
- Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson SyndromeYahoo Finance·Jun 30, 2025
- Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity MarketsYahoo Finance·Jun 25, 2025
All 6 articles loaded
Price Data
52-Week Range
$0.11
Fundamentals
Trading
About Launch One Acquisition Corp - Warrants(13/06/2029)
Launch One Acquisition Corp. Warrant (LPAAW) is a targeted investment vehicle within the Special Purpose Acquisition Company (SPAC) structure, focused on acquiring and merging with high-growth entities across diverse and promising sectors. The firm is supported by a seasoned management team with extensive industry expertise and connections, aimed at identifying and executing transformative mergers that create significant shareholder value. Investors in LPAAW may capitalize on the potential for substantial upside linked to successful acquisition strategies, positioning themselves to benefit from innovation-driven markets with substantial growth prospects.